4-Hydroxy-2,3-dihydroisoindol-1-one
CAS366453-21-6
4-Hydroxy-2,3-dihydroisoindol-1-one (CAS 366453-21-6, C8H7NO2) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 366453-21-6
- Formula
- C8H7NO2
- Mol. weight
- 149.14 g/mol
Chemical Specifications
Identifiers
| CAS number | 366453-21-6 |
|---|---|
| Product name | 4-Hydroxy-2,3-dihydroisoindol-1-one |
| Chinese name | 4-羟基-异吲哚啉-1-酮 |
| Synonyms | 1H-Isoindol-1-one, 2,3-dihydro-4-hydroxy- (9CI) |
| Chinese synonyms | 4-羟基-异吲哚啉-1-酮; 2,3-二氢-4-羟基-1H-异吲哚-1-酮; 4-羟基-2,3-二氢异吲哚-1-酮 |
| Molecular formula | C8H7NO2 |
| Molecular weight | 149.14 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 4-Hydroxy-2,3-dihydroisoindol-1-one?
The CAS Registry Number of 4-Hydroxy-2,3-dihydroisoindol-1-one is 366453-21-6. 4-Hydroxy-2,3-dihydroisoindol-1-one is also known as 1H-Isoindol-1-one, 2,3-dihydro-4-hydroxy- (9CI).
What is the molecular formula and molecular weight of 4-Hydroxy-2,3-dihydroisoindol-1-one?
The molecular formula of 4-Hydroxy-2,3-dihydroisoindol-1-one is C8H7NO2, and its molecular weight is 149.14 g/mol.
How can I request a quotation for 4-Hydroxy-2,3-dihydroisoindol-1-one?
Send an inquiry for 4-Hydroxy-2,3-dihydroisoindol-1-one (CAS 366453-21-6) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 4-Hydroxy-2,3-dihydroisoindol-1-one
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.